Search for: "Exist, Inc." Results 441 - 460 of 25,344
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jan 2024, 4:00 am by Alan Macek
In other contexts, there have been concerns that double patenting may increase burdens under the Notice of Compliance regime for pharmaceuticals – see for example, Glaxosmithkline Inc. v Apotex Inc, 2003 FCT 687 at 90: “The existence of additional patents allows the patent-holder to bring additional applications, thereby obtaining multiple injunctive periods. [read post]
18 Jan 2024, 5:14 pm by bklemm@foley.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The USPTO has issued “Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. [read post]
16 Jan 2024, 12:30 pm by Amy Howe
Apparently because of Jackson’s recusal, the court added Relentless, Inc. v. [read post]
15 Jan 2024, 2:19 pm by Norman L. Eisen
” Most fundamentally in terms of the court’s existing orders, the defense took particular issue with the plaintiff’s request for Trump to, as the Trump legal team put it, “proffer his guilt, under oath, for acts that he maintains did not occur and which were only adjudicated by a jury under a preponderance of evidence standard. [read post]
14 Jan 2024, 9:23 am by Russell Knight
Dudley, 602 NE 2d 934 – Ill: Appellate Court, 4th Dist. 1992 But, “when sufficiently egregious circumstances exist, sanctions can properly be imposed upon a pro se…litigant. [read post]